Standout Papers

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a r... 2012 2026 2016 2021 809
  1. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial (2012)
    Jaafar Bennouna, Javier Sastre et al. The Lancet Oncology
  2. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study (2012)
    Halfdan Sørbye, Staffan Welin et al. Annals of Oncology
  3. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2022)
    Andrés Cervantes, R. Adam et al. Annals of Oncology

Immediate Impact

2 by Nobel laureates 14 from Science/Nature 69 standout
Sub-graph 1 of 19

Citing Papers

Applied body-fluid analysis by wearable devices
2024 StandoutNature
Gut microbiota carcinogen metabolism causes distal tissue tumours
2024 StandoutNature
2 intermediate papers

Works of Pia Österlund being referenced

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study
2007

Author Peers

Author Last Decade Papers Cites
Pia Österlund 2832 984 590 925 95 4.0k
David R. Fogelman 3276 916 494 795 143 4.2k
Marcella M. Johnson 2858 881 194 939 74 5.3k
Michele Nichelatti 1174 1104 216 944 102 3.8k
Carlo Carnaghi 1991 835 512 724 93 3.2k
Francesco Mauri 1987 927 223 860 134 6.0k
Jean‐Marie Michot 3514 910 262 452 199 5.5k
Emmanuel E. Zervos 1854 580 409 749 128 3.6k
Svein Dueland 2865 582 1275 1124 172 5.3k
Gabriela Kornek 3652 1625 660 775 161 6.2k
Thomas Aparicio 3417 1991 357 1425 242 6.2k

All Works

Loading papers...

Rankless by CCL
2026